{"DataElement":{"publicId":"6004318","version":"1","preferredName":"Isotype Immunoglobulin Type","preferredDefinition":"Type of Immunoglobulin","longName":"6003923v1.0:6003919v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"6003923","version":"1","preferredName":"Isotype","preferredDefinition":"An antibody is a type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen._The genetic or structural type for the constant region of an antibody._Something distinguishable as an identifiable class based on common qualities._Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.","longName":"2756911v1.0:2223243v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2756911","version":"1","preferredName":"Immunoglobulin","preferredDefinition":"Glycoproteins present in the blood (ANTIBODIES) and in other tissue. They are classified by structure and activity into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M).","longName":"C572","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin","conceptCode":"C572","definition":"Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EF25823-A0A8-67CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"ONEDATA","dateModified":"2008-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223243","version":"1","preferredName":"Type","preferredDefinition":"A subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F629F5E5-DE63-1DFD-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6F1789-19BB-1149-E053-F662850A9652","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"MAESKEB","dateModified":"2022-03-01","changeDescription":"created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6003919","version":"1","preferredName":"Immunoglobulin Type","preferredDefinition":"A recombinant therapeutic agent which is chemically identical to or similar to the endogenous glycoprotein erythropoietin (Epo).  Epo promotes the differentiation and maturation of hematopoietic progenitors into erythrocytes; is a mitogen and a chemoattractant for endothelial cells; stimulates activated and differentiated B-cells and enhances B-cell immunoglobulin production and proliferation; and is hypoxia-inducible. (NCI04)_Type; a subdivision of a particular kind of thing._Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.","longName":"6003919v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2572577","version":"1","preferredName":"Unknown","longName":"2572577","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"COLBERTM","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-1924-1149-E053-F662850A9652","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"Biclonal","valueDescription":"Biclonal Gammopathy","ValueMeaning":{"publicId":"4221295","version":"1","preferredName":"Biclonal Gammopathy","longName":"4221295","preferredDefinition":"A primary disturbance in immunoglobulin synthesis characterized by the presence of two distinct monoclonal immunoglobulins in the serum or urine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biclonal Gammopathy","conceptCode":"C74936","definition":"A primary disturbance in immunoglobulin synthesis characterized by the presence of two distinct monoclonal immunoglobulins in the serum or urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F494B880-CB7E-130D-E040-BB89AD437019","latestVersionIndicator":"Yes","beginDate":"2014-03-14","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-192F-1149-E053-F662850A9652","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"Non-secretory","valueDescription":"Negation Cellular Secretion","ValueMeaning":{"publicId":"2950909","version":"1","preferredName":"Negation Cellular Secretion","longName":"2950909","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Production by a cell or aggregation of cells (a gland) of a physiologically active substance and its movement out of the cell or organ in which it is formed.  Discharge across the cell membrane, into the intracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cellular Secretion","conceptCode":"C17119","definition":"Production by a cell or aggregation of cells (a gland) of a physiologically active substance and its movement out of the cell or organ in which it is formed.  Discharge across the cell membrane, into the intracellular space or ducts, of endogenous substances resulting from the activity of intact cells of glands, tissues, or organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"755ED4B5-15EC-4EEE-E040-BB89AD436F7F","latestVersionIndicator":"Yes","beginDate":"2009-10-07","endDate":null,"createdBy":"LEATHERJ","dateCreated":"2009-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-193A-1149-E053-F662850A9652","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"Free Light Chain","valueDescription":"Free Immunoglobulin Light Chain","ValueMeaning":{"publicId":"6003921","version":"1","preferredName":"Free Immunoglobulin Light Chain","longName":"6003921","preferredDefinition":"Immunoglobulin kappa and/or lambda light chains that are not bound to immunoglobulin heavy chains. These proteins are produced in vivo by B-cells but can be synthesized ex vivo for use as diagnostic or therapeutic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Free Immunoglobulin Light Chain","conceptCode":"C84258","definition":"Immunoglobulin kappa and/or lambda light chains that are not bound to immunoglobulin heavy chains. These proteins are produced in vivo by B-cells but can be synthesized ex vivo for use as diagnostic or therapeutic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6F1789-1948-1149-E053-F662850A9652","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-1961-1149-E053-F662850A9652","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"IgA","valueDescription":"IgA","ValueMeaning":{"publicId":"2658038","version":"1","preferredName":"IgA","longName":"2658038","preferredDefinition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgA","conceptCode":"C565","definition":"IgA is the immunoglobulin subclass that is associated with antibody-mediated mucosal immunity.  It is secreted as dimers into the mucosa and is the most effective isotype at fixing complement by the alternative pathway, even though it lacks the ability to fix complement by the classical pathway. There are two subtypes in the human - IgA1 and IgA2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90E4-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-196B-1149-E053-F662850A9652","beginDate":"2016-10-19","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"IgD","valueDescription":"IgD","ValueMeaning":{"publicId":"2658039","version":"1","preferredName":"IgD","longName":"2658039","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgD","conceptCode":"C566","definition":"An immunoglobulin isotype (subclass).  This isotype is expressed on naive B cells along with IgM.  Little is known about its physiologic role.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-9126-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-1975-1149-E053-F662850A9652","beginDate":"2016-10-19","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"IgE","valueDescription":"IgE","ValueMeaning":{"publicId":"2658040","version":"1","preferredName":"IgE","longName":"2658040","preferredDefinition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgE","conceptCode":"C567","definition":"An immunoglobulin isotype (subclass).  This isotype has the unique ability to bind with high affinity to IgE receptors (FceRI) on mast cells and basophils and induce degranulation and cytokine production by these cells when they are crosslinked by antigen.  In addition to a central role in atopy and allergic responses, it has been speculated that IgE-mediated mast cell degranulation, by its release of mediators that increase vascular permeability, has an important role in the initiation of immune response in general.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-914C-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated Definition/Description to match NCIt.  Added text \"In addition to...  ...response in general.\" mcolbert 1/9/2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-197F-1149-E053-F662850A9652","beginDate":"2016-10-19","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"IgG","valueDescription":"IgG","ValueMeaning":{"publicId":"2658037","version":"1","preferredName":"IgG","longName":"2658037","preferredDefinition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgG","conceptCode":"C568","definition":"An immunoglobulin isotype (subclass) that characterizes secondary immune responses.  This isotype is further broken down into several smaller subclasses (IgG1, IgG2a, IgG2b, IgG3 in the mouse; IgG1-4 in the human), and each subclass is differentially synthesized and secreted into the serum upon differential immune stimuli.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3356EC85-90C0-2A59-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-20","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2007-06-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-1989-1149-E053-F662850A9652","beginDate":"2016-10-19","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"},{"value":"IgM","valueDescription":"IgM","ValueMeaning":{"publicId":"2568587","version":"1","preferredName":"IgM","longName":"2568587","preferredDefinition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"IgM","conceptCode":"C569","definition":"The major immunoglobulin secreted during a primary immune response.  IgM binds with low affinity but high avidity (multiple binding sites) because it not only occurs as monomers but also as pentamers and hexamers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D8F8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-25","modifiedBy":"CHILLIJ","dateModified":"2007-06-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5B6F1789-1993-1149-E053-F662850A9652","beginDate":"2016-10-19","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"ONEDATA","dateModified":"2017-10-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2756914","version":"1","preferredName":"Immunoglobulin Type","preferredDefinition":"Glycoproteins present in the blood (ANTIBODIES) and in other tissue. They are classified by structure and activity into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M).:Type; a subdivision of a particular kind of thing.","longName":"C572:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunoglobulin","conceptCode":"C572","definition":"Any of the structurally related glycoproteins that function as antibodies. They are divided into five classes (IGA, IGD, IGE, IGG, IGM) on the basis of structure and biological activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4EF18CA1-A906-6F09-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-05","endDate":null,"createdBy":"NYCHM","dateCreated":"2008-06-05","modifiedBy":"ONEDATA","dateModified":"2008-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5B6F1789-190E-1149-E053-F662850A9652","latestVersionIndicator":"Yes","beginDate":"2017-10-13","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-13","modifiedBy":"MAESKEB","dateModified":"2022-03-01","changeDescription":"created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Isotype","type":"Preferred Question Text","description":"Isotype","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BA2AA35-03D7-48D6-E053-F662850A08FA","latestVersionIndicator":"Yes","beginDate":"2017-10-15","endDate":null,"createdBy":"RODGERSC","dateCreated":"2017-10-15","modifiedBy":"MAESKEB","dateModified":"2021-03-11","changeDescription":".created for UAMS 10/15/17 cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}